OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Heather N. Sugrue will serve as the company’s vice-president of Business Development.
Tergus Pharma, a US-based contract development and manufacturing organization (CDMO), announced on March 1, 2021 that Heather N. Sugrue will serve as the company’s vice-president of Business Development.
Prior to her new role at Tergus, Sugrue spent three years at Recro as the vice-president of sales and marketing and six years with Patheon Pharmaceuticals as the senior director of business development for the West Coast, Tergus said in a company press release. Before working at Patheon, Sugrue was employed at Ricerca Biosciences where she supported investigational new drug (IND)-enabling services from lead optimization through IND submission.
“Heather will play a critical role in Tergus’ growth in 2021 and beyond,” said Tergus Pharma chairman and CEO, Dr. Vijendra Nalamothu, in the press release. “Her breadth and depth of sales and business development in the CDMO space will be vital to managing and sustaining our commercial manufacturing expansion while we also maintain our leadership role in topical development. Under Heather’s leadership, Tergus will be expanding the sales team to focus on the growing needs of topical manufacturing in prescription brand and generic manufacturing as well as [over-the-counter] drug product manufacturing.”